Rephonic
Artwork for BioTech Nation ...

BioTech Nation ... with Dr. Moira Gunn

Moira Gunn
FDA
Clinical Trials
Parkinson's Disease
Artificial Intelligence
Cancer
Alzheimer's Disease
Food As Medicine
Autoimmune Diseases
Rheumatoid Arthritis
Covid-19
Drug Discovery
AI In Healthcare
Focused Ultrasound
Cancer Immunotherapy
Longevity
CRISPR
ALS
Epilepsy
Cancer Treatment
UK Biobank

Welcome to BIOTECH NATION !!! With understandable interviews requiring no background in science, BTN attracts a wide global audience. From everyday people looking for hope in treatments in development, to bioentrepreneurs interested in the experience of their fellow travelers, to venture capitalists looking for possibilities in cutting-edge breakthroughs, to scientists simply interested in the wor... more

PublishesWeeklyEpisodes173Founded12 years ago
Number of ListenersCategories
BusinessScienceEntrepreneurshipLife Sciences

Listen to this Podcast

Artwork for BioTech Nation ...

Latest Episodes

In time for the 2026 ASCO Annual Meeting in Chicago, we're highlighting 3 BioTech companies shaping the future of cancer treatment...

On this episode of BioTech Nation, Dr. Will Decker and Jay Hartenbach join Moira to talk about Diakonos Oncology's u... more

In time for the 2026 ASCO Annual Meeting in Chicago, we're highlighting 3 BioTech companies shaping the future of cancer treatment...

On this episode of BioTech Nation: how Syndax Pharmaceuticals got two new drugs approved in the last two years, for... more

In time for the 2026 ASCO Annual Meeting in Chicago, we're highlighting 3 BioTech companies shaping the future of cancer treatment:

On this episode of BioTech Nation, Dan Schmitt of Actuate Therapeutics talks about a new kind of drug showing positiv... more

This week on BioTech Nation, Dr. Jonas Hannestad and Dr. Joanne Taylor of Gain Therapeutics join Moira to discuss a different approach to treating Parkinson's. While treatments are typically focused on relieving symptoms, Gain Therapeutics aims to st... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Science Friday
Science FridayScience Friday and WNYC Studios
The People's Pharmacy
The People's PharmacyJoe and Terry Graedon

Recent Guests

Dr. Jonas Hannestad
Chief Medical Officer, Gain Therapeutics
Gain Therapeutics
Episode: A Different Way to Treat Parkinson's...Dr. Jonas Hannestad & Dr. Joanne Taylor, Gain Therapeutics
Dr. Joanne Taylor
Senior Vice President for Research, Gain Therapeutics
Gain Therapeutics
Episode: A Different Way to Treat Parkinson's...Dr. Jonas Hannestad & Dr. Joanne Taylor, Gain Therapeutics
J. Craig Venter
Geneticist and entrepreneur, prominent genomics figure
Celera Genomics (historical); Synthetic genomics initiatives
Episode: A Life Decoded...A 2007 Interview with Dr. J. Craig Venter
Ashley Magargee
CEO of Genentech
Genentech (Roche Group)
Episode: 50 Years of Genentech...Ashley Magargee, CEO, Genentech
Andrew Farnum
CEO of Variant Bio
Variant Bio
Episode: The Global Diversity of Human Genetics...Andrew Farnum and Sarah LeBaron von Baeyer, Variant Bio
Sarah LeBaron von Baeyer
Senior Director of Ethics and Engagement at Variant Bio
Variant Bio
Episode: The Global Diversity of Human Genetics...Andrew Farnum and Sarah LeBaron von Baeyer, Variant Bio
Dr. Phil Low
Distinguished professor of chemistry, Purdue University; biotech entrepreneur; former director of Purdue Center for Drug Discovery
Purdue University; Endocite (and associated biotech ventures)
Episode: Changing the Future of Cancer Surgery...A 2017 Interview with Dr. Phil Low, Professor & Biotech Entrepreneur
Marschall Runge
Professor at University of Michigan Medical School, former Dean, CEO of Michigan Medicine
University of Michigan Medical School
Episode: Big Tech & Healthcare...Dr. Marschall Runge, Author, "The Great Healthcare Disruption"
Adam Rogers
CEO, NervGen Pharma
NervGen Pharma
Episode: Regaining Function After Spinal Cord Injury: A New Path Forward? Dr. Adam Rogers, CEO, NervGen Pharma

Reviews

4.3 out of 5 stars from 35 ratings
  • It's great to listen to at work

    Discussion of biotechnology future projects along with some current biotech.

    Apple Podcasts
    5
    Magical_smoke
    United States9 years ago
  • I can't say how great it is.

    This podcast always motivates me to study hard,and it gives me very good feeling about biotech,thank you so much for this incredible podcast

    Apple Podcasts
    5
    MReza100
    United States10 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Engaging, accessible take on biotech progress.
Great context on how research translates to real-world impact.
Listener-friendly explanations without sacrificing depth.
Solid guest mix with industry and academic perspectives.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

A Different Way to Treat Parkinson's...Dr. Jonas Hannestad & Dr. Joanne Taylor, Gain Therapeutics
Q: Since you're an MD, we often hear about dopamine in relation to Parkinson's. But tell us, what is this disease and what's it like from early days onward for people who have it?
The disease starts with motor symptoms but includes non-motor aspects as it progresses; neuron loss and dopaminergic dysfunction drive symptoms, and understanding the broad biology helps in targeting disease progression rather than merely symptoms.
50 Years of Genentech...Ashley Magargee, CEO, Genentech
Q: Is it Genentech or Genentech? Which one is it?
People say both; the name is short for genetic engineering technology, and the stock symbol DNA anchors the company's identity.
Changing the Future of Cancer Surgery...A 2017 Interview with Dr. Phil Low, Professor & Biotech Entrepreneur
Q: You've mentioned the possibility of attaching drugs to these targeting molecules as well. How is that being approached and what are the regulatory challenges?
The concept is to repurpose the targeting platform to deliver cytotoxic drugs to cancer cells, but regulatory hurdles are significantly higher for toxic therapies; nonetheless, several targeted-drug candidates are in clinical development, leveraging the same targeting strategy as the imaging dyes.
Changing the Future of Cancer Surgery...A 2017 Interview with Dr. Phil Low, Professor & Biotech Entrepreneur
Q: Now I'm familiar with how you get a new drug past the FDA, and how do you get that complicated dye-to-homing molecule construct approved for human use?
The process starts with extensive animal studies to establish safety and efficacy, followed by carefully phased human trials; the focus is on demonstrating safety and meaningful imaging performance, with only minor adverse events reported in early experiences.
Big Tech & Healthcare...Dr. Marschall Runge, Author, "The Great Healthcare Disruption"
Q: What are the core drivers behind the rising costs of healthcare in the United States?
Dr. Runge points to the complexity of multiple insurance tiers, high administrative costs in private insurance, limited emphasis on proactive public health, and structural incentives in a free-market system that favor treatment over prevention, along with the cost of care delivery and administrative overhead.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About BioTech Nation ...

What is BioTech Nation ... about and what kind of topics does it cover?

Biotech Nation features in-depth conversations with researchers, executives, and clinicians shaping the biotech landscape. Episodes routinely explore new drug targets, clinical trial designs, regulatory considerations, and the practical impact of breakthroughs on patients and healthcare systems. The show often highlights how science translates into therapies, diagnostics, and company strategy, with a recurring emphasis on ethics, funding, and collaboration across academia, industry, and public policy. A notable strength is its ability to translate complex science into actionable insights for investors, entrepreneurs, and informed lay listeners alike.

Where can I find podcast stats for BioTech Nation ...?

Rephonic provides a wide range of podcast stats for BioTech Nation .... We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to BioTech Nation ... and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does BioTech Nation ... get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for BioTech Nation ..., including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for BioTech Nation ...?

Rephonic provides comprehensive predictive audience data for BioTech Nation ..., including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does BioTech Nation ... have?

To see how many followers or subscribers BioTech Nation ... has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to BioTech Nation ...?

These podcasts share a similar audience with BioTech Nation ...:

1. The Readout Loud
2. The Long Run with Luke Timmerman
3. Science Friday
4. The People's Pharmacy
5. TED Radio Hour

How many episodes of BioTech Nation ... are there?

BioTech Nation ... launched 12 years ago and published 173 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact BioTech Nation ...?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for BioTech Nation ...?

Rephonic pulls ratings and reviews for BioTech Nation ... from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for BioTech Nation ...?

Rephonic provides full transcripts for episodes of BioTech Nation .... Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on BioTech Nation ...?

Recent guests on BioTech Nation ... include:

1. Dr. Jonas Hannestad
2. Dr. Joanne Taylor
3. J. Craig Venter
4. Ashley Magargee
5. Andrew Farnum
6. Sarah LeBaron von Baeyer
7. Dr. Phil Low
8. Marschall Runge

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days